Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...
In this video, Anita Afzali, MD, MPH, from The Ohio State University Wexner Medical Center, discusses the key differences between current adult and pediatric health care models, and more.